3-Nitrophthalic anhydride

Intermediate for Pomalidomide. Pomalidomide is a derivative of thalidomide. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide has been approved on February 28, 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.

Specifications

Product Name:                  3-Nitrophthalic anhydride

Synonyms:                         N/A

CAS Number:                     641-70-3

Molecular Weight:            193.1154

Molecular Formula:          C8H3NO5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C1OC(=O)c2c1cccc2[N+](=O)[O-]

3-Nitrophthalic anhydride

  • $69.00
  • Ex Tax: $69.00

Available Options